Business & Finance
RaySearch Laboratories expands product line-up with RayCommand treatment control system; Receives EUR3.6m order from AVO in UK
11 December 2018 -

Medical technology company RaySearch Laboratories AB (RaySearch) (STO:RAYB) announced on Monday its decision to develop a treatment control system, RayCommand.

Reportedly, the first customer of this new system will be Advanced Oncotherapy plc (AVO), a UK based developer of next generation proton therapy technology. AVO will use it for the first LIGHT (Linac Image Guided Hadron Technology) system at the proton therapy facility under construction at Harley Street in central London, UK.

This order for RayCommand is valued at EUR3,6m and is anticipated to generate revenues EUR1,8m within the next 12 months and the remaining part within 36 months.

Currently, RaySearch's main product is RayStation, a treatment planning system for radiation therapy. It is used to produce a sequence of settings for the treatment machine, a so-called treatment plan, designed to produce an optimal distribution of dose in a patient, targeting regions with cancer cells and avoiding surrounding tissues. The planning process involves detailed modelling of patient anatomy and treatment machine components in order to accurately predict and optimize the delivered dose distribution.

By the end of 2017, RaySearch had released the first version of its oncology information system (OIS), RayCare, an OIS is used to coordinate all the complex procedures that are involved in a comprehensive cancer treatment regime. RayCare is designed around patient centric digital workflows that help increase efficiency and quality of care.

Now, RaySearch has decided to develop a treatment control system (TCS), RayCommand. A TCS is the link between the TPS and OIS on one side and the treatment machine on the other. It coordinates and orchestrates the different systems involved, such as the imaging systems, the beam delivery system and the patient support system.

According to the company, this decision to build a TCS is connected to an order from AVO for its first proton therapy facility. AVO has previously purchased RayStation and RayCare for the facility and has now also ordered RayCommand.

As a result, this AVO facility will be the first clinic to use an all RaySearch software suite with both TPS, OIS and TCS. Tight integration between these systems will ensure a safe and efficient treatment process.

RaySearch develops software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare, the next-generation oncology information system, worldwide.